recombinant IgG birch allergen vaccine (Biomay)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant IgG birch allergen vaccine (Biomay)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunoglobulin G modulators
TargetsImmunoglobulin G
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomay Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomay Ag
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A